Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy

References

• Aleksunes, L. M., Cui, Y., Klaassen, C. D. (2008). Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta. Drug Metab Dispos 36:1960–1970.
   PubMed Web of Science ®Google Scholar
• Ali, R., Ozkalemkas, F., Kimya, Y., Koksal, N., Ozkocaman, V., Gulten, T., et al. (2009). Imatinib use during pregnancy and breast feeding: a case report and review of the literature. Arch Gynecol Obstet 280:169–175.
   PubMed Web of Science ®Google Scholar
• Allikmets, R., Schriml, L. M., Hutchinson, A., Romano-Spica, V., Dean, M. (1998). A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 58:5337–5339.
   PubMed Web of Science ®Google Scholar
• Andrade, S. E., Gurwitz, J. H., Davis, R. L., Chan, K. A., Finkelstein, J. A., Fortman, K., et al. (2004). Prescription drug use in pregnancy. Am J Obstet Gynecol 191:398–407.
   PubMed Web of Science ®Google Scholar
• Andrade, S. E., Raebel, M. A., Morse, A. N., Davis, R. L., Chan, K. A., Finkelstein, J. A., et al. (2006). Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf 15:546–554.
   PubMed Web of Science ®Google Scholar
• Atkinson, D. E., Brice-Bennett, S., D’Souza, S. W. (2007). Antiepileptic medication during pregnancy: does fetal genotype affect outcome? Pediatr Res 62:120–127.
   PubMed Web of Science ®Google Scholar
• Atkinson, D. E., Greenwood, S. L., Sibley, C. P., Glazier, J. D., Fairbairn, L. J. (2003). Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer. Am J Physiol Cell Physiol 285:C584–C591.
   PubMed Web of Science ®Google Scholar
• Aye, I. L., Paxton, J. W., Evseenko, D. A., Keelan, J. A. (2007). Expression, localisation, and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes. Placenta 28:868–877.
   PubMed Web of Science ®Google Scholar
• Azuno, Y., Kaku, K., Fujita, N., Okubo, M., Kaneko, T., Matsumoto, N. (1995). Mitoxantrone and etoposide in breast milk. Am J Hematol 48:131–132.
   PubMed Web of Science ®Google Scholar
• Backstrom, G., Taipalensuu, J., Melhus, H., Brandstrom, H., Svensson, A. C., Artursson, P., et al. (2003). Genetic variation in the ATP-binding cassette transporter gene ABCG2 (BCRP) in a Swedish population. Eur J Pharm Sci 18:359–364.
   PubMed Web of Science ®Google Scholar
• Bailey-Dell, K. J., Hassel, B., Doyle, L. A., Ross, D. D. (2001). Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim Biophys Acta 1520:234–241.
   PubMed Web of Science ®Google Scholar
• Bart, J., Hollema, H., Groen, H. J., de Vries, E. G., Hendrikse, N. H., Sleijfer, D. T., et al. (2004). The distribution of drug-efflux pumps, P-gp, BCRP, MRP1, and MRP2, in the normal blood-testis barrier and in primary testicular tumours. Eur J Cancer 40:2064–2070.
   PubMed Web of Science ®Google Scholar
• Beghin, D., Delongeas, J. L., Claude, N., Forestier, F., Farinotti, R., Gil, S. (2009). Development and characterisation of a new model of rat trophoblasts. Toxicol In Vitro 23:141–147.
   PubMed Web of Science ®Google Scholar
• Ben David, S., Einarson, T., Ben David, Y., Nulman, I., Pastuszak, A., Koren, G. (1995). The safety of nitrofurantoin during the first trimester of pregnancy: meta-analysis. Fundam Clin Pharmacol 9:503–507.
   PubMed Web of Science ®Google Scholar
• Bode, C. J., Jin, H., Rytting, E., Silverstein, P. S., Young, A. M., Audus, K. L. (2006). In vitro models for studying trophoblast transcellular transport. Meth Mol Med 122:225–239.
   PubMedGoogle Scholar
• Breedveld, P., Pluim, D., Cipriani, G., Wielinga, P., van Tellingen, O., Schinkel, A. H., et al. (2005). The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients. Cancer Res 65:2577–2582.
   PubMed Web of Science ®Google Scholar
• Capparelli, E., Rakhmanina, N., Mirochnick, M. (2005). Pharmacotherapy of perinatal HIV. Semin Fetal Neonatal Med 10:161–175.
   PubMed Web of Science ®Google Scholar
• Carter, A. M. (2001). Evolution of the placenta and fetal membranes seen in the light of molecular phylogenetics. Placenta 22:800–807.
   PubMed Web of Science ®Google Scholar
• Carter, A. M. (2007). Animal models of human placentation-a review. Placenta 28 (Suppl A):S41–S47.
   PubMed Web of Science ®Google Scholar
• Ceckova-Novotna, M., Pavek, P., Staud, F. (2006). P-glycoprotein in the placenta: expression, localization, regulation, and function. Reprod Toxicol 22:400–410.
   PubMed Web of Science ®Google Scholar
• Ceckova, M., Libra, A., Pavek, P., Nachtigal, P., Brabec, M., Fuchs, R., et al. (2006). Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line, BeWo. Clin Exp Pharmacol Physiol 33:58–65.
   PubMed Web of Science ®Google Scholar
• Cerveny, L., Pavek, P., Malakova, J., Staud, F., Fendrich, Z. (2006). Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents. Epilepsia 47:461–468.
   PubMed Web of Science ®Google Scholar
• Cygalova, L., Ceckova, M., Pavek, P., Staud, F. (2008). Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in rat. Toxicol Lett 178:176–180.
   PubMed Web of Science ®Google Scholar
• Cygalova, L. H., Hofman, J., Ceckova, M., Staud, F. (2009). Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility. J Pharmacol Exp Ther 331:1118–1125.
   PubMed Web of Science ®Google Scholar
• Czeizel, A. E., Rockenbauer, M., Sorensen, H. T., Olsen, J. (2001). Nitrofurantoin and congenital abnormalities. Eur J Obstet Gynecol Reprod Biol 95:119–126.
   PubMed Web of Science ®Google Scholar
• de Jong, F. A., Marsh, S., Mathijssen, R. H., King, C., Verweij, J., Sparreboom, A., et al. (2004). ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition. Clin Cancer Res 10:5889–5894.
   PubMed Web of Science ®Google Scholar
• De Santis, M., Straface, G., Cavaliere, A. F., Rosati, P., Batocchi, A. P., Caruso, A. (2006). The first case of mitoxantrone exposure in early pregnancy. Neurotoxicology 28:696–697.
   PubMed Web of Science ®Google Scholar
• de Zwart, L., Scholten, M., Monbaliu, J. G., Annaert, P. P., Van Houdt, J. M., Van den Wyngaert, I., et al. (2008). The ontogeny of drug metabolizing enzymes and transporters in the rat. Reprod Toxicol 26:220–230.
   PubMed Web of Science ®Google Scholar
• Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., et al. (1998). A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A 95:15665–15670.
   PubMed Web of Science ®Google Scholar
• Ee, P. L., He, X., Ross, D. D., Beck, W. T. (2004a). Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference. Mol Cancer Ther 3:1577–1583.
   PubMed Web of Science ®Google Scholar
• Ee, P. L., Kamalakaran, S., Tonetti, D., He, X., Ross, D. D., Beck, W. T. (2004b). Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res 64:1247–1251.
   PubMed Web of Science ®Google Scholar
• Ek, C. J., Wong, A., Liddelow, S. A., Johansson, P. A., Dziegielewska, K. M., Saunders, NR. (2010). Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat. Toxicol Lett 197:51–59.
   PubMed Web of Science ®Google Scholar
• Elliott, B. D., Langer, O., Schenker, S., Johnson, R. F. (1991). Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 165:807–812.
   PubMed Web of Science ®Google Scholar
• Elliott, B. D., Schenker, S., Langer, O., Johnson, R., Prihoda, T. (1994). Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol 171:653–660.
   PubMed Web of Science ®Google Scholar
• Enders, A. C., Blankenship, T. N. (1999). Comparative placental structure. Adv Drug Deliv Rev 38:3–15.
   PubMed Web of Science ®Google Scholar
• Enokizono, J., Kusuhara, H., Sugiyama, Y. (2007). Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol Pharmacol 72:967–975.
   PubMed Web of Science ®Google Scholar
• Evseenko, D. A., Murthi, P., Paxton, J. W., Reid, G., Emerald, B. S., Mohankumar, K. M., et al. (2007a). The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction. FASEB J 21:3592–3605.
   PubMed Web of Science ®Google Scholar
• Evseenko, D. A., Paxton, J. W., Keelan, J. A. (2006). ABC drug transporter expression and functional activity in trophoblast-like cell lines and differentiating primary trophoblast. Am J Physiol Regul Integr Comp Physiol 290:R1357–R1365.
   PubMed Web of Science ®Google Scholar
• Evseenko, D. A., Paxton, J. W., Keelan, J. A. (2007b). Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors. Drug Metab Dispos 35:595–601.
   PubMed Web of Science ®Google Scholar
• Evseenko, D. A., Paxton, J. W., Keelan, J. A. (2007c). The xenobiotic transporter ABCG2 plays a novel role in differentiation of trophoblast-like BeWo cells. Placenta 28 (Suppl A):S116–S120.
   PubMed Web of Science ®Google Scholar
• Forestier, F., de Renty, P., Peytavin, G., Dohin, E., Farinotti, R., Mandelbrot, L. (2001). Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model. Am J Obstet Gynecol 185:178–181.
   PubMed Web of Science ®Google Scholar
• Fujinaga, M., Brown, N. A., Baden, JM. (1992). Comparison of staging systems for the gastrulation and early neurulation period in rodents: a proposed new system. Teratology 46:183–190.
   PubMedGoogle Scholar
• Gavard, L., Gil, S., Peytavin, G., Ceccaldi, P. F., Ferreira, C., Farinotti, R., et al. (2006). Placental transfer of lopinavir/ritonavir in the ex vivo human cotyledon perfusion model. Am J Obstet Gynecol 195:296–301.
   PubMed Web of Science ®Google Scholar
• Gedeon, C., Anger, G., Piquette-Miller, M., Koren, G. (2008). Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta. Placenta 29:39–43.
   PubMed Web of Science ®Google Scholar
• Geschwind, D. H., Ou, J., Easterday, M. C., Dougherty, J. D., Jackson, R. L., Chen, Z., et al. (2001). A genetic analysis of neural progenitor differentiation. Neuron 29:325–339.
   PubMed Web of Science ®Google Scholar
• Grube, M., Reuther, S., Meyer Zu Schwabedissen, H., Kock, K., Draber, K., Ritter, C. A., et al. (2007). Organic anion transporting polypeptide 2B1 and breast cancer resistance protein interact in the transepithelial transport of steroid sulfates in human placenta. Drug Metab Dispos 35:30–35.
   PubMed Web of Science ®Google Scholar
• Gulati, A., Gerk, P. M. (2009). Role of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancy. J Pharm Sci 98:2317–2335.
   PubMed Web of Science ®Google Scholar
• Gupta, A., Zhang, Y., Unadkat, J. D., Mao, Q. (2004). HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2). J Pharmacol Exp Ther 310:334–341.
   PubMed Web of Science ®Google Scholar
• Hemmings, D. G., Hudson, N. K., Halliday, D., O’Hara, M., Baker, P. N., Davidge, S. T., et al. (2006). Sphingosine-1-phosphate acts via rho-associated kinase and nitric oxide to regulate human placental vascular tone. Biol Reprod 74:88–94.
   PubMed Web of Science ®Google Scholar
• Huls, M., Russel, F. G., Masereeuw, R. (2009). The role of ATP binding cassette transporters in tissue defense and organ regeneration. J Pharmacol Exp Ther 328:3–9.
   PubMed Web of Science ®Google Scholar
• Hutson, J. R., Koren, G., Matthews, S. G. (2010). Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology. Placenta 31:351–357.
   PubMed Web of Science ®Google Scholar
• Ifergan, I., Jansen, G., Assaraf, Y. G. (2005). Cytoplasmic confinement of breast cancer resistance protein (BCRP/ABCG2) as a novel mechanism of adaptation to short-term folate deprivation. Mol Pharmacol 67:1349–1359.
   PubMed Web of Science ®Google Scholar
• Ifergan, I., Shafran, A., Jansen, G., Hooijberg, J. H., Scheffer, G. L., Assaraf, Y. G. (2004). Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis. J Biol Chem 279:25527–25534.
   PubMed Web of Science ®Google Scholar
• Imai, Y., Ishikawa, E., Asada, S., Sugimoto, Y. (2005). Estrogen-mediated post-transcriptional downregulation of breast cancer resistance protein/ABCG2. Cancer Res 65:596–604.
   PubMed Web of Science ®Google Scholar
• Imai, Y., Nakane, M., Kage, K., Tsukahara, S., Ishikawa, E., Tsuruo, T., et al. (2002). C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol Cancer Ther 1:611–616.
   PubMed Web of Science ®Google Scholar
• Ito, S. (2001). Transplacental treatment of fetal tachycardia: implications of drug transporting proteins in placenta. Semin Perinatol 25:196–201.
   PubMed Web of Science ®Google Scholar
• Jenkins, K. J., Correa, A., Feinstein, J. A., Botto, L., Britt, A. E., Daniels, S. R., et al. (2007). Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115:2995–3014.
   PubMed Web of Science ®Google Scholar
• Johnstone, E. D., Chan, G., Sibley, C. P., Davidge, S. T., Lowen, B., Guilbert, L. J. (2005). Sphingosine-1-phosphate inhibition of placental trophoblast differentiation through a G(i)-coupled receptor response. J Lipid Res 46:1833–1839.
   PubMed Web of Science ®Google Scholar
• Johnstone, E. D., Speake, P. F., Sibley, C. P. (2007). Epidermal growth factor and sphingosine-1-phosphate stimulate Na+/H+ exchanger activity in the human placental syncytiotrophoblast. Am J Physiol Regul Integr Comp Physiol 293:R2290–R2294.
   PubMed Web of Science ®Google Scholar
• Jonker, J. W., Buitelaar, M., Wagenaar, E., Van Der Valk, M. A., Scheffer, G. L., Scheper, R. J., et al. (2002). The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci U S A 99:15649–15654.
   PubMed Web of Science ®Google Scholar
• Jonker, J. W., Smit, J. W., Brinkhuis, R. F., Maliepaard, M., Beijnen, J. H., Schellens, J. H., et al. (2000). Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 92:1651–1656.
   PubMed Web of Science ®Google Scholar
• Kalabis, G. M., Petropoulos, S., Gibb, W., Matthews, S. G. (2007). Breast cancer resistance protein (Bcrp1/Abcg2) in mouse placenta and yolk sac: ontogeny and its regulation by progesterone. Placenta 28:1073–1081.
   PubMed Web of Science ®Google Scholar
• Klaassen, C. D., Aleksunes, L. M. (2010). Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 62:1–96.
   PubMed Web of Science ®Google Scholar
• Kliman, H. J., Nestler, J. E., Sermasi, E., Sanger, J. M., Strauss, J. F., 3rd. (1986). Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118:1567–1582.
   PubMed Web of Science ®Google Scholar
• Kobayashi, D., Ieiri, I., Hirota, T., Takane, H., Maegawa, S., Kigawa, J., et al. (2005). Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab Dispos 33:94–101.
   PubMed Web of Science ®Google Scholar
• Kolwankar, D., Glover, D. D., Ware, J. A., Tracy, TS. (2005). Expression and function of ABCB1 and ABCG2 in human placental tissue. Drug Metab Dispos 33:524–529.
   PubMed Web of Science ®Google Scholar
• Koren, G. (2001). Glyburide and fetal safety: transplacental pharmacokinetic considerations. Reprod Toxicol 15:227–229.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy, P., Schuetz, J. D. (2005). The ABC transporter Abcg2/Bcrp: role in hypoxia-mediated survival. Biometals 18:349–358.
   PubMed Web of Science ®Google Scholar
• Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M., Gonzales, O. (2000). A comparison of glyburide and insulin in women with gestational diabetes mellitus. NEJM 343:1134–1138.
   PubMed Web of Science ®Google Scholar
• Langer, O., Yogev, Y., Xenakis, E. M., Rosenn, B. (2005). Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol 192:134–139.
   PubMed Web of Science ®Google Scholar
• Langmann, T., Mauerer, R., Zahn, A., Moehle, C., Probst, M., Stremmel, W., et al. (2003). Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin Chem 49:230–238.
   PubMed Web of Science ®Google Scholar
• Lee, M., Bozzo, P., Einarson, A., Koren, G. (2008). Urinary tract infections in pregnancy. Can Fam Phys 54:853–854.
   PubMed Web of Science ®Google Scholar
• Lee, Y. J., Kusuhara, H., Jonker, J. W., Schinkel, A. H., Sugiyama, Y. (2005). Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein. J Pharmacol Exp Ther 312:44–52.
   PubMed Web of Science ®Google Scholar
• Mao, Q. (2008). BCRP/ABCG2 in the placenta: expression, function, and regulation. Pharm Res 25:1244–1255.
   PubMed Web of Science ®Google Scholar
• Mao, Q., Unadkat, J. D. (2005). Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS J 7:E118–E133.
   PubMed Web of Science ®Google Scholar
• Mathias, A. A., Hitti, J., Unadkat, J. D. (2005). P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol 289:R963–R969.
   PubMed Web of Science ®Google Scholar
• Melamed, N., Yogev, Y. (2009). Can pregnant diabetics be treated with glyburide? Womens Health (Lond) 5:649–658.
   PubMedGoogle Scholar
• Merino, G., Alvarez, A. I., Pulido, M. M., Molina, A. J., Schinkel, A. H., Prieto, J. G. (2006). Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion. Drug Metab Dispos 34:690–695.
   PubMed Web of Science ®Google Scholar
• Merino, G., Jonker, J. W., Wagenaar, E., van Herwaarden, A. E., Schinkel, A. H. (2005). The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin. Mol Pharmacol 67:1758–1764.
   PubMed Web of Science ®Google Scholar
• Meyer Zu Schwabedissen, H. E., Grube, M., Dreisbach, A., Jedlitschky, G., Meissner, K., Linnemann, K., et al. (2006). Epidermal growth factor-mediated activation of the MAP kinase cascade results in altered expression and function of abcg2 (bcrp). Drug Metab Dispos 34:524–533.
   PubMed Web of Science ®Google Scholar
• Meyer Zu Schwabedissen, H. E., Grube, M., Heydrich, B., Linnemann, K., Fusch, C., Kroemer, H. K., et al. (2005). Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: effects of gestational age and cellular differentiation. Am J Pathol 166:39–48.
   PubMed Web of Science ®Google Scholar
• Mihaly, G. W., Morgan, D. J. (1983). Placental drug transfer: effects of gestational age and species. Pharmacol Ther 23:253–266.
   PubMed Web of Science ®Google Scholar
• Mirochnick, M. (2000). Antiretroviral pharmacology in pregnant women and their newborns. Ann N Y Acad Sci 918:287–297.
   PubMed Web of Science ®Google Scholar
• Mitra, P., Audus, K. L (2008). In vitro models and multidrug resistance mechanisms of the placental barrier. In: Ehrhardt, C., Kim, K. J. (Eds.), Drug absorption studies (pp 368–396 ). New York: Springer.
   Google Scholar
• Mitra, P., Audus, K. L. (2010). MRP isoforms and BCRP mediate sulfate conjugate efflux out of BeWo cells. Int J Pharm 384:15–23.
   PubMed Web of Science ®Google Scholar
• Mizuarai, S., Aozasa, N., Kotani, H. (2004). Single nucleotide polymorphisms result in impaired membrane localization and reduced ATPase activity in multidrug transporter ABCG2. Int J Cancer 109:238–246.
   PubMed Web of Science ®Google Scholar
• Mizuno, N., Suzuki, M., Kusuhara, H., Suzuki, H., Takeuchi, K., Niwa, T., et al. (2004). Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice. Drug Metab Dispos 32:898–901.
   PubMed Web of Science ®Google Scholar
• Molsa, M., Heikkinen, T., Hakkola, J., Hakala, K., Wallerman, O., Wadelius, M., et al. (2005). Functional role of P-glycoprotein in the human blood-placental barrier. Clin Pharmacol Ther 78:123–131.
   PubMed Web of Science ®Google Scholar
• Morisaki, K., Robey, R. W., Ozvegy-Laczka, C., Honjo, Y., Polgar, O., Steadman, K., et al. (2005). Single nucleotide polymorphisms modify the transporter activity of ABCG2. Cancer Chemother Pharmacol 56:161–172.
   PubMed Web of Science ®Google Scholar
• Myllynen, P., Kummu, M., Kangas, T., Ilves, M., Immonen, E., Rysa, J., et al. (2008). ABCG2/BCRP decreases the transfer of a food-borne chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in perfused term human placenta. Toxicol Appl Pharmacol 232:210–217.
   PubMed Web of Science ®Google Scholar
• Myllynen, P., Pienimaki, P., Vahakangas, K. (2005). Human placental perfusion method in the assessment of transplacental passage of antiepileptic drugs. Toxicol Appl Pharmacol 207:489–494.
   PubMedGoogle Scholar
• Nanovskaya, T. N., Nekhayeva, I., Hankins, G. D., Ahmed, M. S. (2006). Effect of human serum albumin on transplacental transfer of glyburide. Biochem Pharmacol 72:632–639.
   PubMed Web of Science ®Google Scholar
• Nicholson, W., Bolen, S., Witkop, C. T., Neale, D., Wilson, L., Bass, E. (2009). Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Obstet Gynecol 113:193–205.
   PubMed Web of Science ®Google Scholar
• O’Rahilly, R. (1979). Early human development and the chief sources of information on staged human embryos. Eur J Obstet Gynecol Reprod Biol 9:273–280.
   PubMed Web of Science ®Google Scholar
• Oostendorp, R. L., Buckle, T., Beijnen, J. H., van Tellingen, O., Schellens, J. H. (2009). The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1), and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism, and excretion of imatinib. Invest New Drugs 27:31–40.
   PubMed Web of Science ®Google Scholar
• Oudijk, M. A., Ruskamp, J. M., Ambachtsheer, B. E., Ververs, T. F., Stoutenbeek, P., Visser, G. H., et al. (2002). Drug treatment of fetal tachycardias. Paediatr Drugs 4:49–63.
   PubMedGoogle Scholar
• Pascolo, L., Fernetti, C., Garcia-Mediavilla, M. V., Ostrow, J. D., Tiribelli, C. (2001). Mechanisms for the transport of unconjugated bilirubin in human trophoblastic BeWo cells. FEBS Lett 495:94–99.
   PubMed Web of Science ®Google Scholar
• Pascolo, L., Fernetti, C., Pirulli, D., Crovella, S., Amoroso, A., Tiribelli, C. (2003). Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells. Biochem Biophys Res Commun 303:259–265.
   PubMed Web of Science ®Google Scholar
• Petrovic, V., Teng, S., Piquette-Miller, M. (2007). Regulation of drug transporters during infection and inflammation. Mol Interv 7:99–111.
   PubMed Web of Science ®Google Scholar
• Petrovic, V., Wang, J. H., Piquette-Miller, M. (2008). Effect of endotoxin on the expression of placental drug transporters and glyburide disposition in pregnant rats. Drug Metab Dispos 36:1944–1950.
   PubMed Web of Science ®Google Scholar
• Pollex, E. K., Anger, G., Hutson, J., Koren, G., Piquette-Miller, M. (2010). Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism. Drug Metab Dispos 38:740–744.
   PubMed Web of Science ®Google Scholar
• Pollex, E., Lubetsky, A., Koren, G. (2008). The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta. Placenta 29:743–747.
   PubMed Web of Science ®Google Scholar
• Robey, R. W., To, K. K., Polgar, O., Dohse, M., Fetsch, P., Dean, M., et al. (2009). ABCG2: a perspective. Adv Drug Deliv Rev 61:3–13.
   PubMed Web of Science ®Google Scholar
• Sastry, B. V. (1999). Techniques to study human placental transport. Adv Drug Deliv Rev 38:17–39.
   PubMed Web of Science ®Google Scholar
• Serrano, M. A., Macias, R. I., Briz, O., Monte, M. J., Blazquez, A. G., Williamson, C., et al. (2007). Expression in human trophoblast and choriocarcinoma cell lines, BeWo, Jeg-3, and JAr of genes involved in the hepatobiliary-like excretory function of the placenta. Placenta 28:107–117.
   PubMed Web of Science ®Google Scholar
• Sesink, A. L., Arts, I. C., de Boer, V. C., Breedveld, P., Schellens, J. H., Hollman, P. C., et al. (2005). Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides. Mol Pharmacol 67:1999–2006.
   PubMed Web of Science ®Google Scholar
• Shi, F., Soares, M. J., Avery, M., Liu, F., Zhang, X., Audus, K. L. (1997). Permeability and metabolic properties of a trophoblast cell line (HRP-1) derived from normal rat placenta. Exp Cell Res 234:147–155.
   PubMed Web of Science ®Google Scholar
• Scharenberg, C. W., Harkey, M. A., Torok-Storb, B. (2002). The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99:507–512.
   PubMed Web of Science ®Google Scholar
• Sparreboom, A., Gelderblom, H., Marsh, S., Ahluwalia, R., Obach, R., Principe, P., et al. (2004). Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype. Clin Pharmacol Ther 76:38–44.
   PubMed Web of Science ®Google Scholar
• Sparreboom, A., Loos, W. J., Burger, H., Sissung, T. M., Verweij, J., Figg, W. D., et al. (2005). Effect of ABCG2 genotype on the oral bioavailability of topotecan. Cancer Biol Ther 4:650–658.
   PubMed Web of Science ®Google Scholar
• Staud, F., Pavek, P. (2005). Breast cancer resistance protein (BCRP/ABCG2). Int J Biochem Cell Biol 37:720–725.
   PubMed Web of Science ®Google Scholar
• Staud, F, Vackova, Z, Pospechova, K, Pavek, P, Ceckova, M, Libra, A, et al. (2006). Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line. J Pharmacol Exp Ther 319:53–62.
   PubMed Web of Science ®Google Scholar
• Sudhakaran, S., Ghabrial, H., Nation, R. L., Kong, D. C., Gude, N. M., Angus, P. W., et al. (2005). Differential bidirectional transfer of indinavir in the isolated perfused human placenta. Antimicrob Agents Chemother 49:1023–1028.
   PubMed Web of Science ®Google Scholar
• Sudhakaran, S., Rayner, C. R., Li, J., Kong, D. C., Gude, N. M., Nation, R. L. (2008). Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus. Br J Clin Pharmacol 65:667–673.
   PubMed Web of Science ®Google Scholar
• Syme, M. R., Paxton, J. W., Keelan, J. A. (2004). Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 43:487–514.
   PubMed Web of Science ®Google Scholar
• Takabe, K., Kim, R. H., Allegood, J. C., Mitra, P., Ramachandran, S., Nagahashi, M., et al. (2010). Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J Biol Chem 285:10477–10486.
   PubMed Web of Science ®Google Scholar
• Tanaka, Y., Slitt, A. L., Leazer, T. M., Maher, J. M., Klaassen, C. D. (2005). Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice. Biochem Biophys Res Commun 326:181–187.
   PubMed Web of Science ®Google Scholar
• Taylor, G. P., Low-Beer, N. (2001). Antiretroviral therapy in pregnancy: a focus on safety. Drug Saf 24:683–702.
   PubMed Web of Science ®Google Scholar
• Theiler, K. (1989). The house mouse—atlas of embryonic development. New York: Springer-Verlag.
   Google Scholar
• Utoguchi, N., Chandorkar, G. A., Avery, M., Audus, KL. (2000). Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells. Reprod Toxicol 14:217–224.
   PubMed Web of Science ®Google Scholar
• Vagnerova, K., Vackova, Z., Klusonova, P., Staud, F., Kopecky, M., Ergang, P., et al. (2008). Reciprocal changes in maternal and fetal metabolism of corticosterone in rat during gestation. Reprod Sci 15:921–931.
   PubMed Web of Science ®Google Scholar
• Vahakangas, K., Myllynen, P. (2006). Experimental methods to study human transplacental exposure to genotoxic agents. Mutat Res 608:129–135.
   PubMed Web of Science ®Google Scholar
• van Herwaarden, A. E., Jonker, J. W., Wagenaar, E., Brinkhuis, R. F., Schellens, J. H., Beijnen, J. H., et al. (2003). The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res 63:6447–6452.
   PubMed Web of Science ®Google Scholar
• Vlaming, M. L., Lagas, J. S., Schinkel, AH. (2009). Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv Drug Deliv Rev 61:14–25.
   PubMed Web of Science ®Google Scholar
• Wang, H., Lee, E. W., Zhou, L., Leung, P. C., Ross, D. D., Unadkat, J. D., et al. (2008). Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells. Mol Pharmacol 73:845–854.
   PubMed Web of Science ®Google Scholar
• Wang, H., Unadkat, J. D., Mao, Q. (2007). Hormonal regulation of BCRP expression in human placental BeWo cells. Pharm Res 25:444–452.
   PubMed Web of Science ®Google Scholar
• Wang, H., Wu, X., Hudkins, K., Mikheev, A., Zhang, H., Gupta, A., et al. (2006a). Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors. Am J Physiol Endocrinol Metab 291:E1295–E1304.
   PubMed Web of Science ®Google Scholar
• Wang, H., Zhou, L., Gupta, A., Vethanayagam, R. R., Zhang, Y., Unadkat, J. D., et al. (2006b). Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells. Am J Physiol Endocrinol Metab 290:E798–E807.
   PubMed Web of Science ®Google Scholar
• Wang, X., Furukawa, T., Nitanda, T., Okamoto, M., Sugimoto, Y., Akiyama, S., et al. (2003). Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors. Mol Pharmacol 63:65–72.
   PubMed Web of Science ®Google Scholar
• Wang, X., Nitanda, T., Shi, M., Okamoto, M., Furukawa, T., Sugimoto, Y., et al. (2004). Induction of cellular resistance to nucleoside reverse transcriptase inhibitors by the wild-type breast cancer resistance protein. Biochem Pharmacol 68:1363–1370.
   PubMed Web of Science ®Google Scholar
• Weiss, J., Rose, J., Storch, C. H., Ketabi-Kiyanvash, N., Sauer, A., Haefeli, W. E., et al. (2007). Modulation of human BCRP (ABCG2) activity by anti-HIV drugs. J Antimicrob Chemother 59:238–245.
   PubMed Web of Science ®Google Scholar
• Xu, J., Peng, H., Zhang, J. T. (2007). Human multidrug transporter ABCG2, a target for sensitizing drug resistance in cancer chemotherapy. Curr Med Chem 14:689–701.
   PubMed Web of Science ®Google Scholar
• Yasuda, S., Itagaki, S., Hirano, T., Iseki, K. (2005). Expression level of ABCG2 in the placenta decreases from the mid stage to the end of gestation. Biosci Biotechnol Biochem 69:1871–1876.
   PubMed Web of Science ®Google Scholar
• Yeboah, D., Kalabis, G. M., Sun, M., Ou, R. C., Matthews, S. G., Gibb, W. (2008). Expression and localisation of breast cancer resistance protein (BCRP) in human fetal membranes and decidua and the influence of labour at term. Reprod Fertil Dev 20:328–334.
   PubMed Web of Science ®Google Scholar
• Yeboah, D., Sun, M., Kingdom, J., Baczyk, D., Lye, S. J., Matthews, S. G., et al. (2006). Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can J Physiol Pharmacol 84:1251–1258.
   PubMed Web of Science ®Google Scholar
• Young, A. M., Allen, C. E., Audus, K. L. (2003). Efflux transporters of the human placenta. Adv Drug Deliv Rev 55:125–132.
   PubMed Web of Science ®Google Scholar
• Zamber, C. P., Lamba, J. K., Yasuda, K., Farnum, J., Thummel, K., Schuetz, J. D., et al. (2003). Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine. Pharmacogenetics 13:19–28.
   PubMedGoogle Scholar
• Zamboni, W. C., Ramanathan, R. K., McLeod, H. L., Mani, S., Potter, D. M., Strychor, S., et al. (2006). Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes. Invest New Drugs 24:393–401.
   PubMed Web of Science ®Google Scholar
• Zamek-Gliszczynski, M. J., Hoffmaster, K. A., Humphreys, J. E., Tian, X., Nezasa, K., Brouwer, K. L. (2006). Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat. J Pharmacol Exp Ther 319:459–467.
   PubMed Web of Science ®Google Scholar
• Zhang, W., Yu, B. N., He, Y. J., Fan, L., Li, Q., Liu, Z. Q., et al. (2006a). Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. Clin Chim Acta 373:99–103.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Wang, H., Unadkat, J. D., Mao, Q. (2007). Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. Drug Metab Dispos 35:2154–2158.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Zhou, G., Wang, H., Zhang, X., Wei, F., Cai, Y., et al. (2006b). Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells. Oncology 71:446–455.
   PubMed Web of Science ®Google Scholar
• Zhao, R., Raub, T. J., Sawada, G. A., Kasper, S. C., Bacon, J. A., Bridges, A. S., et al. (2009). Breast cancer resistance protein interacts with various compounds in vitro, but plays a minor role in substrate efflux at the blood-brain barrier. Drug Metab Dispos 37:1251–1258.
   PubMed Web of Science ®Google Scholar
• Zhou, L., Naraharisetti, S. B., Wang, H., Unadkat, J. D., Hebert, M. F., Mao, Q. (2008). The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Mol Pharmacol 73:949–959.
   PubMed Web of Science ®Google Scholar
• Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A. M., Sampath, J., Morris, J. J., et al. (2001). The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7:1028–1034.
   PubMed Web of Science ®Google Scholar